EP1836313A4 - Methods for assessing patients with acute myeloid leukemia - Google Patents

Methods for assessing patients with acute myeloid leukemia

Info

Publication number
EP1836313A4
EP1836313A4 EP05854761A EP05854761A EP1836313A4 EP 1836313 A4 EP1836313 A4 EP 1836313A4 EP 05854761 A EP05854761 A EP 05854761A EP 05854761 A EP05854761 A EP 05854761A EP 1836313 A4 EP1836313 A4 EP 1836313A4
Authority
EP
European Patent Office
Prior art keywords
methods
myeloid leukemia
acute myeloid
assessing patients
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05854761A
Other languages
German (de)
French (fr)
Other versions
EP1836313A2 (en
Inventor
Mitch Raponi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Diagnostics LLC
Original Assignee
Janssen Diagnostics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Diagnostics LLC filed Critical Janssen Diagnostics LLC
Publication of EP1836313A2 publication Critical patent/EP1836313A2/en
Publication of EP1836313A4 publication Critical patent/EP1836313A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/50—Detection characterised by immobilisation to a surface
    • C12Q2565/501—Detection characterised by immobilisation to a surface being an array of oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
EP05854761A 2004-12-17 2005-12-19 Methods for assessing patients with acute myeloid leukemia Withdrawn EP1836313A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63726504P 2004-12-17 2004-12-17
US67011605P 2005-04-11 2005-04-11
US74118005P 2005-12-01 2005-12-01
PCT/US2005/046100 WO2006066240A2 (en) 2004-12-17 2005-12-19 Methods for assessing patients with acute myeloid leukemia

Publications (2)

Publication Number Publication Date
EP1836313A2 EP1836313A2 (en) 2007-09-26
EP1836313A4 true EP1836313A4 (en) 2010-06-30

Family

ID=36588648

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05854761A Withdrawn EP1836313A4 (en) 2004-12-17 2005-12-19 Methods for assessing patients with acute myeloid leukemia

Country Status (9)

Country Link
EP (1) EP1836313A4 (en)
JP (1) JP2008523822A (en)
KR (1) KR20070099564A (en)
AU (1) AU2005316291A1 (en)
BR (1) BRPI0515794A (en)
CA (1) CA2589055A1 (en)
IL (1) IL183555A0 (en)
MX (1) MX2007007401A (en)
WO (1) WO2006066240A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100617467B1 (en) * 2005-09-27 2006-09-01 디지탈 지노믹스(주) Markers for predicting the response of a patient with acute myeloid leukemia to anti-cancer drugs
CN103555825B (en) * 2007-01-31 2015-09-30 俄亥俄州立大学研究基金会 For the method and composition based on microRNA of the diagnosis of acute myelocytic leukemia (AML), prognosis and treatment
EP2056110A1 (en) * 2007-10-31 2009-05-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
EP2272028A1 (en) * 2008-04-25 2011-01-12 Koninklijke Philips Electronics N.V. Classification of sample data
US7736861B1 (en) * 2009-10-19 2010-06-15 Aveo Pharmaceuticals, Inc. Tivozanib response prediction
WO2012007783A1 (en) * 2010-07-13 2012-01-19 Institut Gustave Roussy Kits and methods for detecting the ability to induce an immunogenic cancer cell death in a subject
WO2011131246A1 (en) * 2010-04-22 2011-10-27 Institut Gustave Roussy Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
EP2913405B1 (en) 2010-07-27 2016-11-09 Genomic Health, Inc. Method for using gene expression to determine prognosis of prostate cancer
KR101660322B1 (en) * 2011-04-28 2016-09-29 아크레이 가부시키가이샤 Probe for detecting mutation in exon12 of npm1 gene and use thereof
KR101922761B1 (en) * 2015-11-18 2018-11-27 가톨릭대학교 산학협력단 A Real-time Quantitative PCR Analysis for the c-Kit mutant detection to Diagnose an Acute Myeloid Leukaemia and the Use thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"Affymetrix GeneChip Human Genome U133 Array Set HG-U133A", GEO,, 11 March 2002 (2002-03-11), XP002254749 *
BULLINGER L ET AL: "USE OF GENE-EXPRESSION PROFILING TO IDENTIFY PROGNOSTIC SUBCLASSES IN ADULT ACUTE MYELOID LEUKEMIA", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US LNKD- DOI:10.1056/NEJMOA031046, vol. 350, no. 16, 15 April 2004 (2004-04-15), pages 1605 - 1616, XP009059431, ISSN: 1533-4406 *
GREENBAUM DOV ET AL: "Interrelating different types of genomic data, from proteome to secretome: 'Oming in on function", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, WOODBURY, NY, US, vol. 11, no. 9, 1 September 2001 (2001-09-01), pages 1463 - 1468, XP009088703, ISSN: 1088-9051, DOI: 10.1101/GR.207401 *
KOHLMANN A ET AL: "GENE EXPRESSION PROFILES OF DISTINCT AML SUBTYPES IN COMPARISON TO NORMAL BONE MARROW", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 98, no. 11, PART 01, 16 November 2001 (2001-11-16), XP001108980, ISSN: 0006-4971 *
RAPONI MITCH ET AL: "IDENTIFICATION OF MOLECULAR PREDICTORS OF RESPONSE TO ZARNESTRA (TM) (TIPIFARNIB, R115777) IN RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 104, no. 11, PART 1, 1 November 2004 (2004-11-01), XP009072584, ISSN: 0006-4971 *
SCHOCH CLAUDIA ET AL: "Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US LNKD- DOI:10.1073/PNAS.142103599, vol. 99, no. 15, 23 July 2002 (2002-07-23), pages 10008 - 10013, XP002215484, ISSN: 0027-8424 *
VALK P J M ET AL: "PROGNOSTICALLY USEFUL GENE-EXPRESSION PROFILES IN ACUTE/MYELOID LEUKEMIA", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US LNKD- DOI:10.1056/NEJMOA040465, vol. 350, no. 16, 15 April 2004 (2004-04-15), pages 1617 - 1628, XP009060381, ISSN: 1533-4406 *

Also Published As

Publication number Publication date
CA2589055A1 (en) 2006-06-22
WO2006066240A8 (en) 2006-09-08
WO2006066240A3 (en) 2008-07-17
KR20070099564A (en) 2007-10-09
BRPI0515794A (en) 2008-08-05
IL183555A0 (en) 2007-09-20
AU2005316291A1 (en) 2006-06-22
EP1836313A2 (en) 2007-09-26
WO2006066240A2 (en) 2006-06-22
JP2008523822A (en) 2008-07-10
MX2007007401A (en) 2007-10-08

Similar Documents

Publication Publication Date Title
IL183555A0 (en) Methods for assessing patients with acute myeloid leukemia
IL160891A0 (en) Auto-mix needle
IL218812A0 (en) Stepped cannula
EP1854436A4 (en) Instrument for improving physiological function
GB0426609D0 (en) Analysis
EP1771786A4 (en) Sample multiprocessing
IL161159A0 (en) Tourniquet
GB0419653D0 (en) Needle assembly
EP1731898A4 (en) Fluorescent probes
TWI319785B (en) Plating apparatus
GB0423885D0 (en) Blood analysis
GB0411850D0 (en) Spacing arrangement
EP1811173A4 (en) Slider
DE112005000793D2 (en) Vibrationsgerät für rammgut mit lagern für rotierende unwuchtmassen
GB0406271D0 (en) Diagnostic test
GB0411607D0 (en) Recondenser interface
GB2410799B (en) Fluid-gauging probes
GB0400713D0 (en) Freezing needle
GB0407619D0 (en) Chromium plating
GB0702813D0 (en) Indicator means
GB0401398D0 (en) New theraputic use
GB0423741D0 (en) Improved needle
GB0415328D0 (en) Curved needle holder
GB0409030D0 (en) Needles
GB0412844D0 (en) Probe

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070711

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1107710

Country of ref document: HK

R17D Deferred search report published (corrected)

Effective date: 20080717

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101ALI20080827BHEP

Ipc: C12P 19/34 20060101ALI20080827BHEP

Ipc: C07H 21/04 20060101ALI20080827BHEP

Ipc: C07H 21/02 20060101AFI20080827BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100602

17Q First examination report despatched

Effective date: 20110401

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110812

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1107710

Country of ref document: HK